Design a Western Blot for TGFBI

Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.

Isoforms · The supplied features list one isoform and no alternative sequence. Do not assign additional bands to annotated isoforms without further evidence.

PTM · UniProt lists phosphoserine at position 37 and S-cysteinyl cysteine at position 65. These are UniProt sequence coordinates; antibody or paper numbering may differ. Neither listed modification alone demonstrates a visible band shift.

Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.

Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.

Blocking · Standard workflow guidance: follow the M01218-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.

Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.

Interpretation · The predicted mass is 74.7 kDa, and residues 1..23 are a signal peptide. Account for signal peptide processing when estimating the secreted protein’s mass. No observed band is supplied, so these features do not establish an apparent mass or explain a measured difference.

TGFBI has five annotated disulfide bonds and an S-cysteinyl cysteine at UniProt position 65. Comparing reducing and nonreducing lanes may help assess whether disulfide chemistry affects the pattern. The features do not predict a particular band change.

TGFBI is secreted into extracellular space and the extracellular matrix; it may also associate with microfibrils and the cell surface. Consider the relevant extracellular fraction alongside cell-associated material when choosing samples.

Compare matched sample fractions under the same collection and loading conditions. TGFBI is secreted and can associate with extracellular matrix or the cell surface, so a change in one fraction alone may not represent a change in total TGFBI.

Check bands against the predicted 74.7 kDa mass while accounting for the 1..23 signal peptide. Compare reducing and nonreducing lanes in view of the five disulfide bonds, and assess the relevant extracellular fractions. Confirm band identity before assigning an extra band to a modification or isoform.